← All stocks

Anika Therapeutics, Inc.

ANIK No buying or selling

CIK 0000898437 #3636 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

13 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Blanchard Cheryl R

Director

—

258,788

$5.26M

+69.3%

Colleran David

EVP, General Counsel, Corp Sec

—

67,570

$1.37M

+89.1%

HENNEMAN JOHN B III

Director

—

65,273

$1.33M

+82.8%

Richard Stephen

Director

—

58,273

$1.18M

+72.9%

Fischetti Gary P

Director

—

54,015

$1.10M

+96.8%

CONLEY SHERYL L

Director

—

52,970

$1.08M

+86.5%

Larsen Glenn R.

Director

—

50,258

$1.02M

+39.2%

VOGT SUSAN L N

Director

—

50,213

$1.02M

+39.3%

Griffin Stephen D.

President and CEO

—

45,973

$933.94K

+1,865%

Capper Joseph H

Director

—

30,805

$625.80K

+393.7%

McLeod Ian

SVP, CAO & Treasurer

—

24,107

$489.73K

+40.3%

Nunes Anne

SVP, Chief Operations Officer

—

20,654

$419.59K

+69.6%

Jellison William R

Director

—

20,403

$414.49K

+227.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 4 Nov 2016